세계의 CRISPR 및 Cas 유전자 시장 : 제품 종류별, 기술별, 전달 방법별, 치료 분야별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

CRISPR And Cas Genes Market size was valued at US$ 4,701.29 Million in 2024, expanding at a CAGR of 16.50% from 2025 to 2032.

The CRISPR and Cas Genes Market involves advanced gene-editing technologies used for precise genetic modifications across research, therapeutic, and agricultural applications. Increasing adoption of gene-editing tools for developing personalized medicine and disease-resistant crops boosts innovation, while challenges like ethical concerns and regulatory hurdles limit rapid growth. Growing investments in genetic research have led to a surge in CRISPR patent filings, with over 3,000 patents recorded by major institutions globally. Opportunities lie in expanding applications in rare genetic disorders and regenerative medicine, supported by initiatives from organizations like the National Institutes of Health (NIH), promoting genome editing research. However, complexities in delivery methods and off-target effects pose restraints, underscoring the need for improved accuracy and safety in gene-editing practices.

CRISPR And Cas Genes Market- Market Dynamics

Advancements in Precision Gene Editing to Accelerate Market Growth

Advancements in precision gene editing technologies, particularly involving CRISPR and Cas genes, are significantly accelerating research and therapeutic applications worldwide. According to the National Institutes of Health (NIH), over 70% of gene-editing clinical trials currently focus on CRISPR-Cas systems due to their accuracy and efficiency. The U.S. Food and Drug Administration (FDA) has recently approved several gene therapies utilizing these tools, reflecting growing regulatory acceptance. Furthermore, global initiatives like the Human Genome Project continue to expand understanding of genetic diseases, fueling demand for precise gene-editing solutions. However, challenges such as off-target effects and ethical considerations persist, opening opportunities for innovations that improve safety and delivery. These advancements are fostering a dynamic landscape where precision gene editing plays a pivotal role in addressing complex genetic disorders and advancing personalized medicine.

CRISPR And Cas Genes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.50% over the forecast period (2025-2032)

Based on product type segmentation, the Product was predicted to show maximum market share in the year 2024

Based on Technology segmentation, CRISPR/Cas9 was the leading Technology in 2024

Based on Delivery Method segmentation, Viral Vectors were the leading Delivery Method in 2024

Based on Therapeutic Area segmentation, Oncology was the leading Therapeutic Area in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

CRISPR And Cas Genes Market- Segmentation Analysis:

The Global CRISPR and Cas Genes Market is segmented on the basis of Product Type, Technology, Delivery Method, Therapeutic Area, End User, and Region.

The market is divided into two categories based on product type: Product (Kits & Reagents and Libraries), and Service (Microbial Gene Editing, Cell Line Engineering, gRNA Design & Synthesis, DNA Synthesis, Screening Services, and Others). Product segment leads with Kits & Reagents, including Cas Proteins and Guide RNA, followed by Libraries featuring design tools and antibodies. Services focus on microbial gene editing, cell line engineering, gRNA design, DNA synthesis, and screening, supporting comprehensive gene-editing workflows globally.

The market is divided into three categories based on Technology: CRISPR/Cas9, CRISPR/Cas12, CRISPR/Cas13, and Others. CRISPR/Cas9 dominates with precise gene editing applications, followed by CRISPR/Cas12 used in diagnostics and therapeutics. CRISPR/Cas13 specializes in RNA targeting, while others include emerging variants expanding capabilities across research and clinical settings worldwide.

CRISPR And Cas Genes Market- Geographical Insights

The CRISPR and Cas Genes market shows strong activity across North America, Europe, and Asia-Pacific, driven by robust research infrastructure and government support. North America leads due to substantial funding from agencies like the National Institutes of Health and the presence of leading biotech hubs such as Boston and San Francisco. Europe follows closely, with countries like Germany, the UK, and France advancing gene-editing research through initiatives supported by the European Union's Horizon programs. Asia-Pacific is rapidly growing, especially in China, Japan, and South Korea, where increasing investments in biotechnology and supportive regulatory frameworks are fostering innovation and commercialization. Emerging markets in Latin America and the Middle East are beginning to adopt gene-editing technologies for healthcare and agricultural applications, although at a slower pace. Collaborative efforts and academic partnerships worldwide are further strengthening the global footprint of CRISPR and Cas genes, highlighting the importance of regional expertise and resource availability in advancing the market.

CRISPR And Cas Genes Market- Competitive Landscape:

The competitive landscape of the CRISPR and Cas Genes market is shaped by key biotechnology companies, academic institutions, and innovative startups focusing on advancing gene-editing technologies. Major players such as Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics are actively developing proprietary CRISPR-Cas platforms, with strategic collaborations and licensing agreements expanding their technological capabilities. Academic research centers contribute significantly by discovering new Cas variants and improving delivery methods, fueling innovation. Startups are also emerging with niche technologies, including base editing and prime editing, enhancing precision and reducing off-target effects. Intellectual property rights play a critical role, with ongoing patent disputes influencing competitive dynamics. Partnerships with pharmaceutical companies and research organizations accelerate therapeutic development and commercialization efforts. Additionally, investment in R&D for scalable production and improved bioinformatics tools is intensifying competition, as firms strive to meet growing demand across therapeutic and agricultural applications globally.

Recent Developments:

In November 2024, Vertex and CRISPR Therapeutics received authorization for the world's first CRISPR/Cas9-based gene editing therapy, CASGEVY, for sickle cell disease and transfusion-dependent beta thalassemia, marking a major milestone in the clinical application of CRISPR and Cas gene technologies.

In August 2024, CRISPR QC launched three innovative products-RNP Formation, DNA Target Binding, and CLEAVE-within its CRISPR Analytics Platform, offering real-time insights into CRISPR/Cas gene editing workflows. These tools optimize efficiency, accuracy, and quality control for gene editing research and therapeutic development.

In January 2025, Researchers at Aarhus University unveiled a triple-action CRISPR technology enabling simultaneous gene activation, repression, and deletion in primary human T cells. This breakthrough uses multiple CRISPR/Cas systems, advancing complex genetic engineering for cell therapy and regenerative medicine applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Addgene
• Beam Therapeutics
• Caribou Biosciences
• CRISPR Therapeutics AG
• Editas Medicine
• GenScript Biotech Corporation
• Horizon Discovery Group
• Integrated DNA Technologies (IDT)
• Intellia Therapeutics
• Mammoth Biosciences
• Merck KGaA (Sigma-Aldrich)
• New England Biolabs
• Precision BioSciences
• Synthego Corporation
• Thermo Fisher Scientific
• ToolGen Inc.
• Others

GLOBAL CRISPR AND CAS GENES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Product
• Kits & Reagents
• Cas Proteins & Enzymes
• Guide RNA
• Others
• Libraries
• Design Tool
• Antibodies
• Others
• Service
• Microbial Gene Editing
• Cell Line Engineering
• gRNA Design & Synthesis
• DNA Synthesis
• Screening Services
• Others

GLOBAL CRISPR AND CAS GENES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• CRISPR/Cas9
• CRISPR/Cas12
• CRISPR/Cas13
• Others

GLOBAL CRISPR AND CAS GENES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

• Physical Methods (Electroporation, Microinjection)
• Viral Vectors
• Non-Viral Vectors

GLOBAL CRISPR AND CAS GENES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

• Oncology
• Genetic Disorders
• Infectious Diseases
• Others

GLOBAL CRISPR AND CAS GENES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations (CROs)

GLOBAL CRISPR AND CAS GENES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. CRISPR And Cas Genes Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. CRISPR And Cas Genes Market Snippet by Product Type
  • 2.1.2. CRISPR And Cas Genes Market Snippet by Technology
  • 2.1.3. CRISPR And Cas Genes Market Snippet by Delivery Method
  • 2.1.4. CRISPR And Cas Genes Market Snippet by Therapeutic Area
  • 2.1.5. CRISPR And Cas Genes Market Snippet by End User
  • 2.1.6. CRISPR And Cas Genes Market Snippet by Country
  • 2.1.7. CRISPR And Cas Genes Market Snippet by Region
• 2.2. Competitive Insights

3. CRISPR And Cas Genes Key Market Trends

• 3.1. CRISPR And Cas Genes Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. CRISPR And Cas Genes Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. CRISPR And Cas Genes Market Opportunities
• 3.4. CRISPR And Cas Genes Market Future Trends

4. CRISPR And Cas Genes Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. CRISPR And Cas Genes Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. CRISPR And Cas Genes Market Landscape

• 6.1. CRISPR And Cas Genes Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. CRISPR And Cas Genes Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
  • 7.1.2. Product
    • 7.1.2.1. Kits & Reagents
    • 7.1.2.1.1. Cas Proteins & Enzymes
    • 7.1.2.1.2. Guide RNA
    • 7.1.2.1.3. Others
    • 7.1.2.2. Libraries
    • 7.1.2.2.1. Design Tool
    • 7.1.2.2.2. Antibodies
    • 7.1.2.2.3. Others
  • 7.1.3. Service
    • 7.1.3.1. Microbial Gene Editing
    • 7.1.3.2. Cell Line Engineering
    • 7.1.3.3. gRNA Design & Synthesis
    • 7.1.3.4. DNA Synthesis
    • 7.1.3.5. Screening Services
    • 7.1.3.6. Others

8. CRISPR And Cas Genes Market - By Technology

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
  • 8.1.2. CRISPR/Cas9
  • 8.1.3. CRISPR/Cas12
  • 8.1.4. CRISPR/Cas13
  • 8.1.5. Others

9. CRISPR And Cas Genes Market - By Delivery Method

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
  • 9.1.2. Physical Methods (Electroporation, Microinjection)
  • 9.1.3. Viral Vectors
  • 9.1.4. Non-Viral Vectors

10. CRISPR And Cas Genes Market - By Therapeutic Area

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
  • 10.1.2. Oncology
  • 10.1.3. Genetic Disorders
  • 10.1.4. Infectious Diseases
  • 10.1.5. Others

11. CRISPR And Cas Genes Market - By End User

• 11.1. Overview
  • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 11.1.2. Biotechnology & Pharmaceutical Companies
  • 11.1.3. Academic & Government Research Institutes
  • 11.1.4. Contract Research Organizations (CROs)

12. CRISPR And Cas Genes Market- By Geography

• 12.1. Introduction
  • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 12.2. North America
  • 12.2.1. Overview
  • 12.2.2. CRISPR And Cas Genes Key Manufacturers in North America
  • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 12.2.7. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.2.9. U.S.
    • 12.2.9.1. Overview
    • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.9.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.2.9.6. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.2.10. Canada
    • 12.2.10.1. Overview
    • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.10.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.2.10.6. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.3. Europe
  • 12.3.1. Overview
  • 12.3.2. CRISPR And Cas Genes Key Manufacturers in Europe
  • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 12.3.7. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.9. Germany
    • 12.3.9.1. Overview
    • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.9.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.9.6. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.10. UK
    • 12.3.10.1. Overview
    • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.10.5. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.10.6. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.11. France
    • 12.3.11.1. Overview
    • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.11.6. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.12. Italy
    • 12.3.12.1. Overview
    • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.12.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.12.6. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.13. Spain
    • 12.3.13.1. Overview
    • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.13.5. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.13.6. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.14. The Netherlands
    • 12.3.14.1. Overview
    • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.14.5. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.14.6. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.15. Sweden
    • 12.3.15.1. Overview
    • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.15.5. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.15.6. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.16. Russia
    • 12.3.16.1. Overview
    • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.16.5. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.16.6. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.17. Poland
    • 12.3.17.1. Overview
    • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.17.5. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.17.6. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.18. Rest of Europe
    • 12.3.18.1. Overview
    • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.4. Asia Pacific (APAC)
  • 12.4.1. Overview
  • 12.4.2. CRISPR And Cas Genes Key Manufacturers in Asia Pacific
  • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.4.6. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 12.4.7. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.9. China
    • 12.4.9.1. Overview
    • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.9.6. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.10. India
    • 12.4.10.1. Overview
    • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.10.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.10.6. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.11. Japan
    • 12.4.11.1. Overview
    • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.11.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.11.6. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.12. South Korea
    • 12.4.12.1. Overview
    • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.12.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.12.6. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.13. Australia
    • 12.4.13.1. Overview
    • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.13.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.13.6. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.14. Indonesia
    • 12.4.14.1. Overview
    • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.15. Thailand
    • 12.4.15.1. Overview
    • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.15.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.15.6. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.16. Philippines
    • 12.4.16.1. Overview
    • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.16.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.16.6. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.17. Rest of APAC
    • 12.4.17.1. Overview
    • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.17.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.17.6. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.5. Latin America (LATAM)
  • 12.5.1. Overview
  • 12.5.2. CRISPR And Cas Genes Key Manufacturers in Latin America
  • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.5.6. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 12.5.7. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.9. Brazil
    • 12.5.9.1. Overview
    • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.9.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.9.6. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.10. Mexico
    • 12.5.10.1. Overview
    • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.10.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.10.6. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.11. Argentina
    • 12.5.11.1. Overview
    • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.11.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.11.6. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.12. Colombia
    • 12.5.12.1. Overview
    • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.12.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.12.6. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.13. Rest of LATAM
    • 12.5.13.1. Overview
    • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 12.6. Middle East and Africa
  • 12.6.1. Overview
  • 12.6.2. CRISPR And Cas Genes Key Manufacturers in Middle East and Africa
  • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 12.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  • 12.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.9. Saudi Arabia
    • 12.6.9.1. Overview
    • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.10. United Arab Emirates
    • 12.6.10.1. Overview
    • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.11. Israel
    • 12.6.11.1. Overview
    • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.11.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.11.6. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.12. Turkey
    • 12.6.12.1. Overview
    • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.12.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.12.6. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.13. Algeria
    • 12.6.13.1. Overview
    • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.13.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.13.6. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.14. Egypt
    • 12.6.14.1. Overview
    • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.14.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.14.6. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.15. Rest of MEA
    • 12.6.15.1. Overview
    • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.15.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.15.6. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- CRISPR And Cas Genes Industry

• 13.1. Competitive Dashboard
  • 13.1.1. Competitive Benchmarking
  • 13.1.2. Competitive Positioning
• 13.2. Company Profiles
  • 13.2.1. Addgene
  • 13.2.2. Beam Therapeutics
  • 13.2.3. Caribou Biosciences
  • 13.2.4. CRISPR Therapeutics AG
  • 13.2.5. Editas Medicine
  • 13.2.6. GenScript Biotech Corporation
  • 13.2.7. Horizon Discovery Group
  • 13.2.8. Integrated DNA Technologies (IDT)
  • 13.2.9. Intellia Therapeutics
  • 13.2.10. Mammoth Biosciences
  • 13.2.11. Merck KGaA (Sigma-Aldrich)
  • 13.2.12. New England Biolabs
  • 13.2.13. Precision BioSciences
  • 13.2.14. Synthego Corporation
  • 13.2.15. Thermo Fisher Scientific
  • 13.2.16. ToolGen Inc.
  • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

• 15.1. Research Methodology
• 15.2. References
• 15.3. Abbreviations
• 15.4. Disclaimer
• 15.5. Contact Us